NEW YORK (GenomeWeb) – Rennova Health said today that it has acquired the 85 percent stake in pharmacogenetics testing firm Genomas that it did not already own.

Hartford, Connecticut-based Genomas has developed and offers the PhyzioType System for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease and diabetes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

Stat News reports that the head of IBM Watson Health is leaving her post.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.